Revenue: As of FY2025 Q3, the actual value is USD 388.71 M.EPS: As of FY2025 Q3, the actual value is USD -0.68.EBIT: As of FY2025 Q3, the actual value is USD -60.31 M.<h3>Segment Revenue</h3><ul><li>SHOP (Senior Housing Operating Portfolio): Revenue for the three months ended September 30, 2025, was $333.39 million, an increase from $312.01 million in the same period in 2024. For the nine months ended September 30, 2025, revenue was $989.24 million, up from $928.65 million in 2024.</li><li>Medical Office and Life Science Portfolio: Revenue for the three months ended September 30, 2025, was $48.20 million, down from $52.90 million in the same period in 2024. For the nine months ended September 30, 2025, revenue was $146.02 million, down from $161.61 million in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: For the three months ended September 30, 2025, the net loss was $164.04 million, compared to a net loss of $98.69 million in the same period in 2024. For the nine months ended September 30, 2025, the net loss was $264.67 million, compared to $282.81 million in 2024.</li><li>NOI (Net Operating Income):<ul><li>SHOP: NOI for the three months ended September 30, 2025, was $29.62 million, up from $27.43 million in 2024. For the nine months ended September 30, 2025, NOI was $103.06 million, up from $81.13 million in 2024.</li><li>Medical Office and Life Science Portfolio: NOI for the three months ended September 30, 2025, was $26.68 million, down from $27.83 million in 2024. For the nine months ended September 30, 2025, NOI was $80.02 million, down from $88.35 million in 2024.</li></ul></li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Net cash provided by operating activities for the nine months ended September 30, 2025, was $0.49 million, compared to $94.03 million in 2024.</li><li>Investing Cash Flow: Net cash provided by investing activities for the nine months ended September 30, 2025, was $276.15 million, compared to net cash used of $120.88 million in 2024.</li><li>Financing Cash Flow: Net cash used in financing activities for the nine months ended September 30, 2025, was $216.88 million, compared to net cash provided of $41.29 million in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is focused on optimizing performance in its SHOP segment by reviewing the results of each senior living community and operator, with a strategy to drive positive performance through potential dispositions or transitions to different operators.</li><li>Non-Core Business: The company is transitioning the management of 116 senior living communities from Five Star to new managers, with 85 communities already transitioned as of November 3, 2025, and expects to complete the transitions by December 31, 2025.</li><li>Priority: The company is closely monitoring economic and market conditions, including interest rates, inflation, and labor market conditions, which could impact financial performance and strategic decisions.</li></ul>

Diversified Healthcare Pref Share DHCNL 6.25 02/01/46 | 10-Q: FY2025 Q3 Revenue: USD 388.71 M